Neupro

Active Ingredient(s): Rotigotine
FDA Approved: * May 9, 2007
Pharm Company: * SCHWARZ
Category: Parkinsons

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Neupro Overview

Rotigotine (trade name Neupro) is a dopamine agonist of the non-ergoline class of medications indicated for the treatment of Parkinson's disease (PD) and restless legs syndrome (RLS).[1][2] It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours.[1][1] Like other dopamine agonists, rotigotine has been shown to possess antidepressant effects and may be us...

Read more Neupro Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Rotigotine

Recent Neupro Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Rotigotine
  • Film, Extended Release: 1mg/24hr, 2mg/24hr, 3mg/24hr, 4mg/24hr, 6mg/24hr, 8mg/24hr
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Neupro: (7 results)

Sorted by National Drug Code
  • 50474-801 Neupro 1 mg/24h Transdermal Patch, Extended Release by Ucb, Inc.
  • 50474-802 Neupro 2 mg/24h Transdermal Patch, Extended Release by Ucb, Inc.
  • 50474-803 Neupro 3 mg/24h Transdermal Patch, Extended Release by Ucb, Inc.
  • 50474-804 Neupro 4 mg/24h Transdermal Patch, Extended Release by Ucb, Inc.
  • 50474-805 Neupro 6 mg/24h Transdermal Patch, Extended Release by Ucb, Inc.
  • 50474-806 Neupro 8 mg/24h Transdermal Patch, Extended Release by Ucb, Inc.
  • 50474-808 Neupro Kit by Ucb, Inc.

Other drugs which contain Rotigotine or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA